Note: This section contains information in English only.
Wed, 15 Jan 2025 03:30:03 GMT
Source: Dukascopy Bank SA
Pfizer CEO Albert Bourla said the company is focused on developing its obesity drug, danuglipron, with plans for a late-stage study in the second half of the year.
For further information regarding potential cooperation, please call us or make callback request.
To learn more about Dukascopy Bank Binary Options
/ Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Crypto Trading / CFD / Forex trading platform, SWFX and other trading related information, please call us or make callback request.
To learn more about Business Introducer and other trading related information, please call us or make callback request.
For further information regarding potential cooperation, please call us or make callback request.